Page 2 - J&j

Top headlines: India fast-tracks approval for vaccines; Bitcoin near $63k

From govt fast-tracking approval for foreign-produced Covid vaccines to JLR reporting over 12% rise in Q4 retail sales, here are top headlines this evening.

Johnson & Johnson CEO pay irks investors upset with opioid lawsuits fallout

(Reuters) - Johnson & Johnson is coming under fire from some investors who are raising questions about companies that give their chief executives hefty pay raises despite facing billions of dollars in legal costs over their role in the U.S. opioid crisis.

Biden plans to order 100 million more J&J coronavirus vaccine doses

US President Joe Biden has said that his administration will order another 100 million doses of the Johnson & Johnson Covid-19 vaccine.

J&J applies to WHO for emergency use listing of Covid-19 vaccine

J&J said an emergency use listing is a prerequisite for supplying vaccines to the COVAX vaccine program, co-led by WHO, which aims to deliver doses to poor and middle-income countries

J&J's vaccine implementation study in South Africa gets regulator nod

South Africa has yet to launch its Covid-19 vaccination programme and the government has decided to go with the J&J dose

UK, EU nations rally behind Astra jab after South Africa halts roll-out

South Africa looks to J&J vaccine

J&J confirms pausing Covid-19 vaccine trial because of unexplained illness

Earlier this month, Johnson & Johnson joined the short list of vaccine makers that have moved an experimental coronavirus shot into late-stage human studies

Some volunteers quit J&J Covid-19 trial in Spain after AstraZeneca scare

MADRID (Reuters) - Some volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday.

Hyderabad-based Biological E joins hands with J&J for Covid-19 vaccine

The vaccine candidate is in phase 1/2a clinical trials

Johnson & Johnson wins 4th verdict in a row, cleared in US baby powder case

The baby powder of Johnson & Johnson is not responsible for a Missouri woman's cancer, a jury in the US has decided in the company's latest win in a litigation case over its famous product. The litigation case (Forrest) in St Louis, Missouri in the US has resulted in a verdict for Johnson & Johnson, finding Johnson's baby powder was not the cause of the Vickie Forrest's disease. "This is the fourth consecutive verdict in favour of Johnson & Johnson in these cases and the eighth defense verdict this year," a Johnson & Johnson company spokesperson said in a statement. The jury carefully considered the decades of independent clinical evidence, which show Johnson's Baby Powder is safe, does not contain asbestos, and does not cause cancer, it added. "We know that anyone suffering from cancer is searching for answers, which is why the science and facts on this topic are so important," the statement said.

J&J's own expert working for FDA found asbestos in baby powder sample

(Reuters) - Ever since Johnson & Johnson disclosed this month that a government test had turned up asbestos in its Baby Powder, the company has attacked the validity of the result.

Delhi HC sets ball rolling on J&J's faulty hip implant damages

Firm willing to pay RS 25 lakh only to 'revision surgery' patients, not others

J&J loses motion to overturn $4.7 billion talc-ovarian cancer verdict

(Reuters) - Healthcare conglomerate Johnson & Johnson has lost its motion to reverse a verdict that awarded $4.7 billion to women who blamed ovarian cancer on asbestos in the company's Baby Powder and other talc products, a Missouri court ruled on Wednesday.

J&J scandal is India's wake-up call to reform rules for medical devices

The absence of compensation provisions in the Drugs & Cosmetics Act puts the spotlight on the gaps in the regulatory regime

J&J powders tested positive for asbestos from 1971 to the early 2000s

Company executives, mine managers, scientists, doctors and lawyers fretted over the problem and how to address it while failing to disclose it to regulators or the public

Faulty hip implants case: J&J agrees to pay compensation, says govt

The government wrote to J&J's subsidiary DePuy Medical, which made the devices, asking them to provide compensation till 2025

J&J's largest India plant to be operational by 2018

J&J's India bet comes at a time when it has faced consumer ire in the US